Bowel Cancer: Symptoms, Diagnosis, Screening & NHS Treatment

Bowel cancer (colorectal cancer) is the fourth most common cancer in the UK and the second most common cause of cancer death, with approximately 42,000 new cases and 16,000 deaths each year. The good news is that bowel cancer is one of the most preventable and treatable cancers when detected early — over 90% of people diagnosed at the earliest stage (Stage 1) survive for 5 or more years, compared to less than 10% at the most advanced stage (Stage 4). This is why the NHS bowel cancer screening programme — one of the world’s most comprehensive — is so important.

Symptoms of Bowel Cancer

Bowel cancer symptoms vary depending on where in the bowel the cancer is located. The main symptoms to be aware of are:

  • Blood in stools — bright red or dark red blood mixed with or on top of stools; any unexplained rectal bleeding should be reported to your GP
  • A persistent change in bowel habit — looser stools, more frequent bowel movements, or constipation lasting 3 or more weeks without explanation
  • Unexplained weight loss
  • Unexplained fatigue or tiredness — often from anaemia caused by slow bowel bleeding
  • Abdominal pain, discomfort, or bloating — especially after eating
  • A lump in the abdomen or back passage

See your GP within 2 weeks if you have any of these symptoms — particularly blood in stools or a persistent change in bowel habit. The NHS 2-week wait urgent cancer referral pathway means you should be seen by a specialist within 2 weeks of GP referral if cancer is suspected.

NHS Bowel Cancer Screening: Know Your Entitlements

The NHS Bowel Cancer Screening Programme offers free screening to:

Faecal Immunochemical Test (FIT) — Ages 50–74

In England, everyone aged 50–74 receives a FIT kit by post every 2 years. The test detects tiny traces of blood in a stool sample. It is simple, at-home, and highly effective — detecting cancer early before symptoms appear. A positive FIT result does not mean you have cancer, but triggers further investigation (colonoscopy). The sensitivity of the FIT test is approximately 70–80% for detecting bowel cancer.

Bowel Scope Screening — Flexible Sigmoidoscopy (England)

A one-off flexible sigmoidoscopy was offered to people at age 55 in England but this programme has been phased out in favour of extending FIT screening to age 50.

Colonoscopy Surveillance for High-Risk Groups

People at higher risk receive colonoscopy surveillance (every 3–5 years) rather than FIT screening:

  • Those with a personal or family history of bowel polyps (adenomas)
  • Those with hereditary bowel cancer syndromes — Lynch syndrome, Familial Adenomatous Polyposis (FAP)
  • People with long-standing inflammatory bowel disease (Crohn’s colitis or extensive ulcerative colitis of 8+ years)

Risk Factors for Bowel Cancer

  • Age — over 90% of bowel cancers occur in people aged 50 or over
  • Diet — high in processed and red meat; low in fibre; WCRF recommends eating no more than 500g cooked red meat per week and avoiding processed meat
  • Obesity — particularly abdominal obesity
  • Physical inactivity
  • Smoking
  • Alcohol — even moderate alcohol consumption increases risk
  • Family history — 5–10% of bowel cancers are inherited; first-degree relative with bowel cancer increases risk 2–3 fold
  • Previous bowel polyps — adenomatous polyps are pre-cancerous
  • Inflammatory bowel disease — long-standing Crohn’s colitis or ulcerative colitis
  • Type 2 diabetes — associated with modestly increased risk

Diagnosis: NHS Bowel Cancer Tests

  • Colonoscopy — gold standard; examines entire colon; polyps can be removed (polypectomy) at the same time
  • Flexible sigmoidoscopy — examines the lower colon only; less complete than colonoscopy
  • CT colonography (virtual colonoscopy) — CT scan of the colon; used when colonoscopy is not suitable (elderly or frail patients)
  • Biopsy — tissue samples taken during colonoscopy to confirm cancer
  • CT scan of chest, abdomen, and pelvis — staging scan to assess spread
  • MRI pelvis — essential staging for rectal cancer; guides surgical and radiotherapy planning

NHS Treatment for Bowel Cancer

All NHS bowel cancer treatment decisions are made by a specialist multidisciplinary team (MDT) — including colorectal surgeons, oncologists, radiologists, pathologists, and specialist nurses. Treatment depends on cancer stage, location, and individual fitness.

Surgery

Surgery is the main treatment for non-metastatic bowel cancer:

  • Laparoscopic (keyhole) surgery — now the standard approach for most colon cancers in the UK; faster recovery than open surgery; equivalent outcomes
  • Hemicolectomy — removal of the affected portion of colon
  • Anterior resection — for upper rectal cancer; bowel reconnected after removal
  • Abdominoperineal resection (APR) — for low rectal cancer; requires permanent colostomy
  • Hartmann’s procedure — for emergency presentations or when bowel reconnection is not immediately possible
  • TAMIS/TEM — trans-anal minimally invasive surgery for very early rectal cancers

Chemotherapy

  • Adjuvant chemotherapy — given after surgery for Stage 3 colon cancer and high-risk Stage 2; typically CAPOX (capecitabine + oxaliplatin) or FOLFOX for 3–6 months
  • Palliative chemotherapy — for Stage 4 (metastatic) disease; FOLFOX, FOLFIRI, or XELIRI regimens; median survival has improved from 6 months to 30+ months with modern treatment
  • Targeted agents — bevacizumab (Avastin), cetuximab (Erbitux) for specific RAS-wildtype or MSI-high cancers
  • Immunotherapy — pembrolizumab (Keytruda) for MSI-high/dMMR metastatic colorectal cancer; NICE approved 2021 (TA793)

Radiotherapy (Rectal Cancer)

Short-course pre-operative radiotherapy or long-course chemoradiotherapy is used for rectal cancer to shrink tumours before surgery, reducing local recurrence rates. “Watch and wait” (no surgery) is a strategy increasingly used for complete responders to chemoradiotherapy.

Living With a Stoma

Some people require a temporary or permanent stoma (colostomy or ileostomy) after bowel cancer surgery. NHS stoma care nurses provide comprehensive support. Products are available on NHS prescription. Colostomy UK (colostomyuk.org) provides peer support and practical advice.

UK Support and Resources

  • Bowel Cancer UK — bowelcanceruk.org.uk | Helpline: 0800 8 40 35 40 | UK’s leading bowel cancer charity; “Never Too Young” campaign for under-50s
  • Colostomy UK — colostomyuk.org | Support for people living with stomas
  • Macmillan Cancer Support — macmillan.org.uk | Helpline: 0808 808 0000
  • NHS Bowel Cancer Screening — nhs.uk/conditions/bowel-cancer-screening

What Major Health Sites Often Miss About Bowel Cancer

1. The UK’s FIT-Based Screening Programme Starting at Age 50

England’s extension of NHS bowel cancer screening to age 50 (from 60) represents a major public health advance. In Scotland, Wales, and Northern Ireland, screening programmes vary slightly. US health sites primarily describe colonoscopy-based screening starting at 45 — quite different from the UK’s postal FIT kit approach, which has high population participation rates and avoids the discomfort and cost of colonoscopy for average-risk people. UK patients should know that FIT is a validated, accurate screening test — not just a triage tool.

2. Watch and Wait for Rectal Cancer Complete Responders

The “watch and wait” strategy — where rectal cancer patients who show complete clinical response to chemoradiotherapy are monitored closely without surgery — is an evolving UK approach gaining momentum at specialist centres. Studies show similar long-term outcomes to surgery with organ preservation. This option is not yet widely implemented across all NHS trusts and is not mentioned on most mainstream health sites, but represents a significant quality-of-life benefit for eligible patients.

Related Health Guides on YourHealthXpert